Further Developments

Transthoracic echocardiography shows a left ventricular ejection fraction of 35%. Dr. McPhee reviews the results with Mr. Green and explains that these findings are consistent with heart failure. Mr. Green’s HbA1c is 8.2%. He arranges follow‑up with cardiology for guideline‑directed medical therapy and with endocrinology to coordinate diabetes management. Dr McPhee reinforces daily medication adherence and regular follow-ups.

At the cardiology visit, the cardiologist explains that, over the next few weeks, several medications will be started and titrated to treat Mr Green’s heart failure. He adds that one of the new drugs will also be beneficial for Mr. Green’s type 2 diabetes and has been shown to have positive effects on cardiovascular outcomes.

Which medication is the most appropriate choice that benefits both heart failure and type 2 diabetes for Mr. Green?

  • Παραμονή στο νοσοκομείο και 24ωρη παρακολούθηση [undo]
  • FOLLOW UP ΕΝΑ ΕΤΟΣ ΚΑΙ CT [undo]
  • Μόνος [undo]
  • Descrierea 3 [undo]
  • -Ρήξη του κυστικού αυχένα [undo]
  • -Άμεση ανοικτή χειρουργική αποκατάσταση της συνέχειας της ουρήθρας [undo]
  • Καρδιοαναπνευστικός έλεγχος [undo]
  • Περαιτέρω εργαστηριακός έλεγχος [undo]
  • Γενική ούρων - Καλλιέργεια ούρων [undo]
  • Έναρξη ινσουλίνης [undo]
  • Δίαιτα [undo]
  • Descrierea 1 [undo]
  • Sitagliptin [undo]
  • -Όψιμη ενδοσκοπική αποκατάσταση της συνέχειας της ουρήθρας μετά 3 μήνες [undo]
  • To avoid our Professor telling us off [undo]
  • Further Developments [undo]

Map: Michael Green_GEMD_2 (1116)
Node: 21133
Score:

reset

OpenLabyrinth
OpenLabyrinth is an open source educational pathway system

Review your pathway